Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 14, 2016
Total Value: $531M (99.5% shares, 0.5% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BLUEPRINT MEDICINES CORP | 2,765,080 | $82.12M | 15.5% | — | — | COM | 09627Y109 |
| — | CHEMOCENTRYX INC | 8,064,019 | $48.71M | 9.2% | — | — | COM | 16383L106 |
| CYTK | CYTOKINETICS INC | 4,997,071 | $45.87M | 8.6% | — | — | COM NEW | 23282W605 |
| — | ARRAY BIOPHARMA INC | 6,461,186 | $43.61M | 8.2% | — | — | COM | 04269X105 |
| — | CASCADIAN THERAPEUTICS INC | 18,799,368 | $30.83M | 5.8% | — | — | COM | 14740B101 |
| — | FORWARD PHARMA A/S | 1,387,853 | $29.14M | 5.5% | — | — | SPONSORED ADR | 34986J105 |
| — | COLUCID PHARMACEUTICALS INC | 763,300 | $29.12M | 5.5% | — | — | COM | 19716T101 |
| — | CONCERT PHARMACEUTICALS INC | 2,723,210 | $27.53M | 5.2% | — | — | COM | 206022105 |
| XENE | XENON PHARMACEUTICALS INC | 3,108,905 | $25.18M | 4.7% | — | — | COM | 98420N105 |
| — | ONCOMED PHARMACEUTICALS INC | 1,812,005 | $20.71M | 3.9% | — | — | COM | 68234X102 |
| — | GLYCOMIMETICS INC | 2,426,282 | $17.35M | 3.3% | — | — | COM | 38000Q102 |
| — | CTI BIOPHARMA CORP | 44,796,940 | $16.77M | 3.2% | — | — | COM | 12648L106 |
| — | TOBIRA THERAPEUTICS INC | 399,433 | $15.87M | 3.0% | — | — | COM | 88883P101 |
| — | NIVALIS THERAPEUTICS INC | 1,709,673 | $13.9M | 2.6% | — | — | COM | 65481J109 |
| — | ARQULE INC | 7,400,128 | $13.25M | 2.5% | — | — | COM | 04269E107 |
| CTMX | CYTOMX THERAPEUTICS INC | 591,813 | $9.28M | 1.7% | — | — | COM | 23284F105 |
| — | IMMUNE DESIGN CORP | 1,200,000 | $9.096M | 1.7% | — | — | COM | 45252L103 |
| — | GTX INC DEL | 11,512,000 | $9.014M | 1.7% | — | — | COM | 40052B108 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 5,149,644 | $8.033M | 1.5% | — | — | COM | 45665G303 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 375,000 | $7.924M | 1.5% | — | — | COM | 74366E102 |
| ESPR | ESPERION THERAPEUTICS INC NE | 493,872 | $6.84M | 1.3% | — | — | COM | 29664W105 |
| — | ADURO BIOTECH INC | 501,155 | $6.229M | 1.2% | — | — | COM | 00739L101 |
| — | SUNESIS PHARMACEUTICALS INC | 730,361 | $3.192M | 0.6% | — | — | COM PAR | 867328700 |
| — | OREXIGEN THERAPEUTICS INC | 10,000,000 | $2.65M | 0.5% | — | — | NOTE 2.750%12/0 | 686164AB0 |
| — | OREXIGEN THERAPEUTICS INC | 734,976 | $2.44M | 0.5% | — | — | COM NEW | 686164302 |
| — | PAIN THERAPEUTICS INC | 2,278,552 | $2.278M | 0.4% | — | — | COM | 69562K100 |
| — | PIERIS PHARMACEUTICALS INC | 1,016,593 | $1.858M | 0.4% | — | — | COM | 720795103 |
| — | CATALYST BIOSCIENCES INC | 865,773 | $1.048M | 0.2% | — | — | COM | 14888D109 |
| GBIM | GLOBEIMMUNE INC | 657,653 | $822K | 0.2% | — | — | COM | 37957B100 |